French agency withdraws nine rubella tests
This article was originally published in Clinica
The French Medicines Agency has ordered the withdrawal of nine rubella antibody detection tests from the French market. Seven had not been presented for evaluation which, under the rules of the agency, means that licences are automatically withdrawn.
You may also be interested in...
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.
Move was meant to preempt others’ efforts to secure the next six months of Regeneron’s COVID-19 antibody therapeutic.